The Supreme Court (SC) in its decision of 5 October 2015, in the
matter of Neon Laboratories Ltd. v Medical Technologies Ltd and Ors
(Neon Laboratories case), noted that "[T]he "first
user" rule is a seminal part of the [Trade Marks]
Act" and passed an order based upon the said principle,
while deciding a trade mark dispute. In the present article, we aim
to discuss the SC's interpretation of Section 34 of the Trade
Marks Act, 1999 (TM Act) and the application of "first
user" rule in the Neon Laboratories case.
The facts of the said case are as follows: the
Plaintiff-Respondent, Medical Technologies Ltd (MTL) is engaged in
the business of manufacturing and marketing of pharmaceutical
products. MTL had been using the mark 'PROFOL' since the
year 2000 and its predecessor-in-title had commenced use of the
same in April 1998. When the Defendant-Appellant, Neon Laboratories
Ltd (Neon) introduced the same generic drug under the trade mark
'ROFOL', MTL filed a suit for